Vitamin D Receptor [aapp, rcpt]
treatment [ftcn]
secondary [neop]
Hyperparathyroidism [dsyn]
Hyperparathyroidism, Secondary [dsyn]
Common [qnco]
Serious [qlco]
Consequence of [ftcn]
Chronic kidney disease [dsyn]
Hyperparathyroidism, Secondary [dsyn]
Complex [qlco]
condition [dsyn]
dihydroxyvitamin d [phsu, strd, vita]
Consequence [ftcn]
Vitamin D Receptor [aapp, rcpt]
Activation [acty]
Abnormalities [cgab]
serum calcium [lbtr]
Phosphorus [elii]
Levels [qlco]
Parathyroid hyperplasia [dsyn]
Gland [bpoc]
Elevated parathyroid hormone [fndg]
secretion [biof]
Systemic [ftcn]
Mineral [inch]
Bone [bpoc]
Abnormalities [cgab]
Three [qnco]
Class [inpr]
Drugs [phsu]
treatment [ftcn]
Hyperparathyroidism, Secondary [dsyn]
I- [inch]
Vitamin D Receptor [aapp, rcpt]
agonists [phsu]
III [inpr]
ACT [topp]
Vitamin D Receptor [aapp, rcpt]
ACT [topp]
Calcium-Sensing Receptor [aapp, rcpt]
therapy [ftcn]
Chemical Structure [inpr]
effects [qlco]
Gene Expression [genf]
Parathyroid gland [bpoc]
Bone [bpoc]
Intestine [bpoc]
function [phsf]
Medications [phsu]
Three [qnco]
Class [inpr]
effective [qlco]
Suppression [patf]
Parathyroid Hormone [aapp, horm, phsu]
Clinical Studies [resa]
Show [inpr]
Associated [qlco]
Unfavorable [qlco]
TOLERABILITY [resa]
Profile [lbpr]
Hypocalcaemia [patf]
Lesser [qlco]
Extent [spco]
Associated [qlco]
Dose-Limiting [idcn]
Hypercalcaemia [dsyn]
Hyperphosphataemia [dsyn]
Minimal [qlco]
undesirable effects [ftcn]
Calcium [bacs, elii, phsu]
Absorption [npop]
Intestine [bpoc]
Calcium [bacs, elii, phsu]
Phosphorus [elii]
Mobilisation [topp]
Bone [bpoc]
Compared [acty]
Calcium [bacs, elii, phsu]
Load [idcn]
Patients [podg]
With [qlco]
Consequence of [ftcn]
Chronic kidney disease [dsyn]
???lead [elii, hops]
Vascular calcification [patf]
Accelerated [ftcn]
progression [patf]
Cardiovascular disease [dsyn]
Increased [qnco]
Mortality [qnco]
High [qlco]
Serum Phosphorus Level [lbpr]
Associated [qlco]
adverse effects [ftcn]
function [phsf]
Survival [acty]
Recent [tmco]
Evidence [ftcn]
Suggest [idcn]
Associated [qlco]
Survival [acty]
Benefit [qnco]
In [qnco]
Consequence of [ftcn]
Chronic kidney disease [dsyn]
Patients [podg]
More [ftcn]
Favorable [qlco]
Effect [qlco]
paricalcitol [orch, phsu, vita]
Reported [inpr]
To [qlco]
exert [orgf]
Specific [qlco]
effects [qlco]
Gene Expression [genf]
Various [irda]
Cell types [inpr]
Involved [ftcn]
Vascular calcification [patf]
development [phsf]
coronary artery disease [dsyn]
This [euka]
Article [inpr]
Molecular [qlco]
Mechanisms [ftcn]
Review [inpr]
Evidence [ftcn]
Clinical [qlco]
Efficacy [qlco]
Safety [hcpp]
Survival [acty]
Associated [qlco]
Three [qnco]
Drug [phsu]
Class [inpr]
treatment [ftcn]
Hyperparathyroidism, Secondary [dsyn]
In [qnco]
Consequence of [ftcn]
Chronic kidney disease [dsyn]
Patients [podg]
